Mckinley Capital Management LLC Bio Techne Corp Transaction History

Mckinley Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$73.76 - $85.98 $346,672 - $404,106	-4,700 Reduced 11.49%	36,220 $2.96 Million
Q4 2022 Jan 18, 2023	BUY	$80.67 - $352.29 $2.48 Million - $10.8 Million	30,690 Added 300.0%	40,920 $0
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $1.1 Million - $1.33 Million	2,470 Added 31.83%	10,230 $4.96 Million
Q1 2021 Apr 21, 2021	BUY	$314.62 - $411.0 $1.42 Million - $1.86 Million	4,520 Added 139.51%	7,760 $2.96 Million
Q4 2019 Jan 23, 2020	BUY	$189.68 - $222.09 $614,563 - $719,571	3,240 New	3,240 $711,000
Q3 2019 Nov 12, 2019	SELL	$183.56 - $216.72 $594,734 - $702,172	-3,240 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$188.72 - $215.43 $611,452 - $697,993	3,240 New	3,240 $676,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.94B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mckinley Capital Management LLC with notifications on news.